|4May 26, 4:42 PM ET

Bacopoulos Nicholas G 4

4 · Cyclacel Pharmaceuticals, Inc. · Filed May 26, 2011

Insider Transaction Report

Form 4
Period: 2011-05-24
Transactions
  • Award

    Option

    2011-05-24+25,00025,000 total
    Exercise: $1.53Exp: 2021-05-24Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]These options are exercisable over a four-year period with 1/48 of the options granted vesting on a monthly basis.
  • [F2]The options were granted to Dr. Bacopoulos for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.

Documents

1 file
  • 4
    c17945_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION